These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 1540653
1. Interpretation of the roles of adenylosuccinate lyase and of AMP deaminase in the anti-HIV activity of 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine. Nair V, Sells TB. Biochim Biophys Acta; 1992 Feb 26; 1119(2):201-4. PubMed ID: 1540653 [Abstract] [Full Text] [Related]
2. Enzymatic phosphorylation and pyrophosphorylation of 2',3'-dideoxyadenosine-5'-monophosphate, a key metabolite in the pathway for activation of the anti-HIV (human immunodeficiency virus) agent 2',3'-dideoxyinosine. Navé JF, Eschbach A, Wolff-Kugel D, Halazy S, Balzarini J. Biochem Pharmacol; 1994 Sep 15; 48(6):1105-12. PubMed ID: 7945403 [Abstract] [Full Text] [Related]
3. Cellular phosphorylation of 2',3'-dideoxyadenosine-5'-monophosphate, a key intermediate in the activation of the antiviral agent DDI, in human peripheral blood mononuclear cells. Robbins BL, Greenhaw J, Fridland A. Nucleosides Nucleotides Nucleic Acids; 2000 Sep 15; 19(1-2):405-13. PubMed ID: 10772723 [Abstract] [Full Text] [Related]
4. Intracellular activation of 2',3'-dideoxyinosine and drug interactions in vitro. Kewn S, Hoggard PG, Henry-Mowatt JS, Veal GJ, Sales SD, Barry MG, Back DJ. AIDS Res Hum Retroviruses; 1999 Jun 10; 15(9):793-802. PubMed ID: 10381167 [Abstract] [Full Text] [Related]
5. Anomalous accumulation and decay of 2',3'-dideoxyadenosine-5'-triphosphate in human T-cell cultures exposed to the anti-HIV drug 2',3'-dideoxyinosine. Ahluwalia G, Cooney DA, Hartman NR, Mitsuya H, Yarchoan R, Fridland A, Broder S, Johns DG. Drug Metab Dispos; 1993 Jun 10; 21(2):369-76. PubMed ID: 8097711 [Abstract] [Full Text] [Related]
6. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT). Periclou AP, Nandy P, Avramis VI. In Vivo; 2000 Jun 10; 14(3):377-88. PubMed ID: 10904870 [Abstract] [Full Text] [Related]
7. cycloSal-Pronucleotides of 2',3'-dideoxyadenosine and 2', 3'-dideoxy-2',3'-didehydroadenosine: synthesis and antiviral evaluation of a highly efficient nucleotide delivery system. Meier C, Knispel T, De Clercq E, Balzarini J. J Med Chem; 1999 May 06; 42(9):1604-14. PubMed ID: 10229629 [Abstract] [Full Text] [Related]
13. Role of altered metabolism in dideoxynucleoside pharmacokinetics. Studies of 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats. Singhal D, Morgan ME, Anderson BD. Drug Metab Dispos; 1996 Oct 06; 24(10):1155-61. PubMed ID: 8894519 [Abstract] [Full Text] [Related]
14. Role of brain tissue localized purine metabolizing enzymes in the central nervous system delivery of anti-HIV agents 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats. Singhal D, Morgan ME, Anderson BD. Pharm Res; 1997 Jun 06; 14(6):786-92. PubMed ID: 9210198 [Abstract] [Full Text] [Related]
15. Uptake and distribution of 2',3'-dideoxyinosine and its derivatives in a human monocytoid cell line. Vázquez-Padua MA, Mayol N, López M. Cell Mol Biol (Noisy-le-grand); 1995 Jun 06; 41 Suppl 1():S113-9. PubMed ID: 8574139 [Abstract] [Full Text] [Related]
16. Enzymes of the purine nucleotide cycle in muscle of patients with exercise intolerance. Operti MG, Vincent MF, Brucher JM, van den Berghe G. Muscle Nerve; 1998 Mar 06; 21(3):401-3. PubMed ID: 9486871 [Abstract] [Full Text] [Related]
17. Enhancement by 2'-deoxycoformycin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of 2',3'-dideoxyadenosine and 2'-beta-fluoro-2',3'-dideoxyadenosine. Ahluwalia GS, Cooney DA, Shirasaka T, Mitsuya H, Driscoll JS, Johns DG. Mol Pharmacol; 1994 Nov 06; 46(5):1002-8. PubMed ID: 7969062 [Abstract] [Full Text] [Related]
18. Enzymatic properties of the unnatural beta-L-enantiomers of 2',3'-dideoxyadenosine and 2',3'-didehydro-2',3'-dideoxyadenosine. Pélicano H, Pierra C, Eriksson S, Gosselin G, Imbach JL, Maury G. J Med Chem; 1997 Nov 21; 40(24):3969-73. PubMed ID: 9397178 [Abstract] [Full Text] [Related]
19. In vitro and in vivo evaluation of 6-azido-2',3'-dideoxy-2'-fluoro-beta-D-arabinofuranosylpurine and N6-methyl-2',3'-dideoxy-2'-fluoro-beta-D-arabinofuranosyladenine as prodrugs of the anti-HIV nucleosides 2'-F-ara-ddA and 2'-F-ara-ddI. Koudriakova T, Manouilov KK, Shanmuganathan K, Kotra LP, Boudinot FD, Cretton-Scott E, Sommadossi JP, Schinazi RF, Chu CK. J Med Chem; 1996 Nov 08; 39(23):4676-81. PubMed ID: 8917656 [Abstract] [Full Text] [Related]
20. Simultaneous determination of 2',3'-dideoxyinosine and the active metabolite, 2',3'-dideoxyadenosine-5'-triphosphate in human peripheral-blood mononuclear cell by HPLC-MS/MS and the application to cell pharmacokinetics. Lan X, Mingdao L, Huilin G, Wei G, Lvjiang H, Yan Z, Gang L. J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Oct 01; 1002():337-42. PubMed ID: 26350426 [Abstract] [Full Text] [Related] Page: [Next] [New Search]